The Cigna Group (NYSE:CI) reported first-quarter 2026 results that surpassed analyst expectations, driven by strong performance in its Evernorth health services division and improved margins within its core insurance arm.
Total revenues for the period reached $68.5 billion, a 5% increase year-over-year, as the company benefited from higher pharmacy volumes and disciplined medical cost management.
Shareholders' net income for the quarter was $1.7 billion, or $6.26 per share.
On an adjusted basis, income from operations stood at $2.1 billion, or $7.79 per share, reflecting a resilient operating model despite broader macroeconomic shifts in the healthcare sector.
The quarter was also marked by the financial effects of the HCSC transaction, part of Cigna's ongoing effort to sharpen its focus on high-growth areas like specialty pharmacy and Medicare Advantage.
Evernorth, the company’s health services brand, remained a primary engine of growth, benefiting from expanded partnerships and the rising demand for specialty medications.
Simultaneously, Cigna Healthcare saw a notable improvement in its medical care ratio, supported by pricing discipline and a favorable evolution in legacy claims.
Reflecting the momentum across its business units, Cigna raised its full-year 2026 adjusted income from operations outlook to at least $30.35 per share.